Toggle navigation
Leadership in clinical care
HOME
CE
TOPICS
Case Reports
Coding
Contact Lenses & Solutions
Cornea
Diagnostics
Dry Eye
Eyelids
Glaucoma
Low Vision
Neuro-ophthalmic Disorders
News
Ophthalmic Lenses & Dispensary
Optometric Study Center
Pharmaceuticals
Practice Management
Products
Retina
Surgery
Systemic Disease
Technology
Multimedia
Web Exclusives
EVENTS
CE Programs
Educational Programs (Non-CE)
JOBS
Ocular Surface Review
OSD Management in Glaucoma Patients
How to minimize the use of drops while treating both conditions.
08/15/2024
As Smooth As Silk
This unique protein is a brand new DED treatment.
05/15/2024
Shining the Slit Lamp on ADCs
ODs can greatly help ovarian cancer patients who are taking this advanced therapeutic agent, specifically Elahere.
03/15/2024
Not So Benign OSD
If your patient isn’t responding to treatment, look beyond the typical forms of ocular surface disease.
11/15/2023
Call the Exterminator
A new eye drop, Xdemvy, shows positive results in wiping out the unusually common condition known as Demodex blepharitis.
09/15/2023
First of its Kind
Miebo now gives us a medication option that targets MGD and evaporative DED.
07/15/2023
Drink Up
Hydrating the whole body—not just the eyes—is key to improving the ocular surface.
05/15/2023
Toxic Work Environment
Be aware of certain glaucoma therapy options that could harm the ocular surface.
03/15/2023
Right Tool for the Job
These small but mighty instruments can help you better perform a number of procedures and will enhance your practice.
02/15/2023
Making the Grade
Studies show promising results for CyclASol, a new medication to treat DED that could be approved next year.
11/15/2022
LOAD MORE
Current Issue
Table of Contents
Read Digital Edition
Read PDF Edition
Archive
Subscriptions
×
Full Image